New Drug Shows Promise Against Huntington’s Disease ( )



Dr. Andrew Feigin, Director, Experimental Therapeutics Unit, Susan and Leonard Feinstein Center for Neurosciences, part of the North Shore-LIJ Health System, discusses the promising investigational drug, pridopidine, which may be a safe and effective treatment for those patients with Huntington's disease.

Read the full story.